OE-275 A Spironolactone Derivative, Potassium Canrenoate, Prolongs the QT Interval but Shortens the Electrically Vulnerable Period of In Vivo Canine Hearts(Cardiovascular Pharmacology, Basic/Clinical 1 (H) : OE34)(Oral Presentation (English))
Nanae Kada, Ryozo Nagai(Jichi Medical University), Takayoshi Matsumura(Jichi Medical University), Yoshiko Munemasa, Yoshiko Mizuno(Development Bank of Japan), Kana Sasaki, T. Suzuki, Kenichi Aizawa(Jichi Medical University), Norifumi Takeda(University of Tokyo Hospital)
Japanese Circulation Journal-english Edition
March 1, 2004
Cited by 0
Related Papers
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Clinical Profiles and Outcomes of Acute Type B Aortic Dissection in the Current Era: Lessons From the International Registry of Aortic Dissection (IRAD)
|Circulation|2003|587
Gene Expression in Fibroblasts and Fibrosis
|Circulation Research|2002|512
Circulating Oxidized Low Density Lipoprotein Levels
|Arteriosclerosis Thrombosis and Vascular Biology|2000|406